MANAGEMENT OF CIN
Ablative therapy is not recommended if the SCJ and/or the limits of the lesion cannot be seen colposcopically.
A negative ECC prior to ablative therapy has been suggested by experts.
An ECC at the time of LEEP/cone may indicate an increased risk of residual disease but may not influence post-LEEP/cone management.
“See and treat” approach for low-grade lesions leads to a significant number of patients with negative histology.